Publications

CPCAD Members - Authors or Co-Authors

 

Méhul B, Laffet G, Séraïdaris A, Russo L, Fogel P, Carlavan I, Pernin C, Andres P, Queille-Roussel C, Voegel JJ. Non-invasive proteome analysis of psoriatic stratum corneum reflects pathophysiological pathways and is useful for drug profiling.Br J Dermatol. 2017 Jan 27. doi: 10.1111/bjd.15346.

 

Queille-Roussel C, Rosen M, Clonier F, Nørremark K, Lacour JP. Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis. Clin Drug Investig. 2017 Apr;37(4):355-361. doi: 10.1007/s40261-016-0489-5.

 

Rzany B, Bayerl C, Bodokh I, Boineau D, Dirschka T, Queille-Roussel C, Sebastian M, Sommer B, Edwartz C, Podda M. An 18-Month Follow-up, Randomized Comparison of Effectiveness and Safety of Two Hyaluronic Acid Fillers for Treatment of Moderate Nasolabial Folds. Dermatol Surg. 2017 Jan;43(1):58-65. doi: 10.1097/DSS.0000000000000923.

 

Duteil l, Queille-Roussel L, Maubert Y, Esdaile J, Bruno-Bonnet C, Lacour JP. Specific natural bioactive type 1 collagen peptides oral intake reverse skin aging signs in mature women. J Aging Res Clin Practice, 2016, Vol 5, N° 2: 84-92. doi : 10.14283/jarcp.2016.97

 

Queille-Roussel C, Bang B, Clonier F, Lacour JP. Enhanced vasoconstrictor potency of the fixed combination calcipotriol plus betamethasone dipropionate in an innovative aerosol foam formulation vs. other corticosteroid psoriasis treatments.J Eur Acad Dermatol Venereol. 2016 Nov;30(11):1951-1956. doi: 10.1111/jdv.13714

 

Queille-Roussel C, Olesen M, Villumsen J, Lacour JP. Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris. Clin Drug Investig. 2015 Apr;35(4):239-45. doi: 10.1007/s40261-015-0269-7. 

 

Nguyen S, Chiaverini C, Cardot-Leccia N, Queille-Roussel C, Roussel K, Lacour JP, Bahadoran P. Optical coherence tomography-assisted diagnosis of follicular keratosis of the chin. J Eur Acad Dermatol Venereol. 2015 Feb 11. doi: 10.1111/jdv.13030.

 

Queille-Roussel C, Clonier F, Olesen M. Alternative treatment with calcipotriol plus betamethasone dipropionate gel in psoriasis vulgaris using a short-contact approach. Br J Dermatol. 2014 Dec; 171(6):1596-8. 

 

Khemis A, Duteil L, Tillet Y, Dereure O, Ortonne JP. Evaluation of the activity and safety of CS21 barrier genital gel® compared to topical aciclovir and placebo in symptoms of genital herpes recurrences: a randomized clinical trial. J Eur Acad Dermatol Venereol 2014 Sep; 28(9):1158-64.  

 

Duteil L, Cardot-Leccia N, Queille-Roussel C, Maubert Y, Harmelin Y, Boukari F, Ambrosetti D, Lacour JP, Passeron T. Differences in visible light induced-pigmentation according to wavelengths: a clinical and histological study in comparison with UVB exposure. Pigment Cell Melanoma Res 2014; 27, 822-826. 

 

Duteil LRoussel K, Bahadoran P. Measuring skin color and pigmentation disorders. in Atlas of pigmentary disorders (Springer Switzerland), Editors Ortonne JP, Passeron T, 2014; 16-24. 

 

Montaudié H, Lacour JP, Rostain G, Duteil L, Passeron T. Solar urticaria to visible light triggered by light-emitting diode therapy. J Am Acad Dermatol. 2014 Sep; 71(3):e74-5 

  

Queille-Roussel C, Hoffmann V, Enevold A, Ganslandt C. Use of a psoriasis plaque test in the development of a gel formulation of calcipotriol and betamethasone dipropionate for scalp psoriasis. J Dermatolog Treat. 2013 Aug;24(4):250-4. 

  

Queille-Roussel C, Hoffmann V, Ganslandt C, Hansen KK. Comparison of the antipsoriatic effect and tolerability of calcipotriol-containing products in the treatment of psoriasis vulgaris using a modified psoriasis plaque test. Clin Drug Investig. 2012 Sep 1;32(9):613-9. 

 

Khemis A, Duteil L, Coudert AC, Tillet Y, Dereure O, Ortonne JP. Evaluation of the efficacy and safety of a CS20(®) protective barrier gel containing OGT compared with topical aciclovir and placebo on functional and objective symptoms of labial herpes recurrences: a randomized clinical trial. J Eur Acad Dermatol Venereol. 2012 Oct;26(10):1240-6 

 

Tsilika K, Levy JL, Kang HY, Duteil L, Khemis A, Hughes R, Passeron T, Ortonne JP. A pilot study using reflectance confocal microscopy (RCM) in the assessment of a novel formulation for the treatment of melasma. J Drugs Dermatol. 2011 Nov 1;10(11):1260-4

 

Ralfkiaer U, Hagedorn PH, Bangsgaard N, Løvendorf MB, Ahler CB, Svensson L, Kopp KL, Vennegaard MT, Lauenborg B, Zibert JR, Krejsgaard T, Bonefeld CM, Søkilde R, Gjerdrum LM, Labuda T, Mathiesen AM, Grønbæk K, Wasik MA, Sokolowska-Wojdylo M, Queille-Roussel C, Gniadecki R, Ralfkiaer E, Geisler C, Litman T, Woetmann A, Glue C, Røpke MA, Skov L, Odum N. Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood. 2011 Nov 24;118(22):5891-900. doi: 10.1182/blood-2011-06-358382.


Rzany B, Bayerl C, Bodokh I, Boineau D, Dirschka T, Queille-Roussel C, Sebastian M, Sommer B, Poncet M, Guennoun M, Podda M. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Laser Ther. 2011 Jun;13(3):107-12. doi: 10.3109/14764172.2011.571699


Turlier V, Rouquier A, Black D, Josse G, Auvergnat A, Briant A, Dahan S, Gassia V, Saint-Martory C, Zakaria W, Queille-Roussel C, Grognard-Gourdon C, Thioly-Bensoussan D, Degouy A, Schmitt AM. Assessment of the clinical efficacy of a hyaluronic acid-based deep wrinkle filler using new instrumental methods. J Cosmet Laser Ther. 2010 Aug;12(4):195-202. doi: 10.3109/14764172.2010.502461

 

Bouilly-Gauthier D, Jeannes C, Maubert Y, Duteil L, Queille-Roussel C, Piccardi N, Montastier C, Manissier P, Piérard G, Ortonne JP. Clinical evidence of benefits of a dietary supplement containing probiotic and carotenoids on ultraviolet-induced skin damage  

  

Ortonne JP, Zartarian M, Verschoore M, Queille-Roussel C, Duteil L.

 

Guéniche A, Cathelineau AC, Bastien P, Esdaile J, Martin R, Queille Roussel C, Breton L. Vitreoscilla filiformis biomass improves seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2008 Aug;22(8):1014-5.

 

Ortonne JP, Queille-Roussel CEvaluation of the effect of Dardia Lipo Line on skin inflammation induced by surfactants using the repeated open-application test. J Eur Acad Dermatol Venereol. 2007 Sep;21 Suppl 2:19-25.

 

Kienzler JL, Queille-Roussel C, Mugglestone C, Ortonne JP, Larnier C. Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses. Curr Med Res Opin. 2007 Jun;23(6):1293-302.

Ortonne JP, Queille-Roussel C, Duteil L3% diclofenac in 2.5% hyaluronic acid (Solaraze) does not induce photosensitivity or phototoxicity alone or in combination with sunscreens. Eur J Dermatol. 2006 Jul-Aug;16(4):385-90.

 

Duteil L, Queille-Roussel C, Ortonne JP. [Assessment of the photosensitization potential of zinc gluconate]. Ann Dermatol Venereol. 2005 Mar;132(3):219-24. French.

 

Kienzler JL, Magnette J, Queille-Roussel C, Sanchez-Ponton A, Ortonne JP. Diclofenac-Na gel is effective in reducing the pain and inflammation associated with exposure to ultraviolet light - results of two clinical studies. Skin Pharmacol Physiol. 2005 May-Jun;18(3):144-52.

 

Duteil L, Queille-Roussel C, Lorenz B, Thieroff-Ekerdt R, Ortonne JP. A randomized, controlled study of the safety and efficacy of topical corticosteroid treatments of sunburn in healthy volunteers. Clin Exp Dermatol. 2002 Jun;27(4):314-8.

 

Duteil L, Queille-Roussel C, Rougier A, Richard A, Ortonne JP. Chronic UVA exposure: protective effect on skin induced pigmentation by a daily use of a day  care cream containing broad band sunscreen. Eur J Dermatol. 2002 Jul-Aug;12(4):XVII-XVIII.

 

Moyal D, Duteil L, Queille-Roussel C, Ortonne JP, Hourseau C, Richard A, Rougier A. Prevention of solar-induced immunosuppression by a new highly protective broadspectrum sunscreen. Eur J Dermatol. 2002 Jul-Aug;12(4):XII-XIV.

 

Duteil L, Queille-Roussel C, Rougier A, Richard A, Ortonne JP. Highprotective effect of a broad-spectrum sunscreen against tetracycline phototoxicity. Eur J Dermatol. 2002 Jul-Aug;12(4):X-XI. PubMed PMID: 12118428.

  

Moyal D, Duteil L, Queille-Roussel C, Ortonne JP, Richard A, Rougier A. Comparison of UVA protection afforded by sunscreens with a high sun protection factor. Eur J Dermatol. 2002 Jul-Aug;12(4):II-III.

 

Queille-Roussel C, Duteil L, Parneix-Spake A, Arsonnaud S, Rizova E. The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity. Eur J Dermatol. 2001 May-Jun;11(3):219-24.

 

Queille-Roussel C, Poncet M, Mesaros S, Clucas A, Baker M, Soloff AM.

Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel. Clin Ther. 2001 Feb;23(2):205-12.

 

Queille-Roussel C, Paul C, Duteil L, Lefebvre MC, Rapatz G, Zagula M, Ortonne JP. The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br J Dermatol. 2001 Mar;144(3):507-13.

 

Queille-Roussel C, Graeber M, Thurston M, Lachapelle JM, Decroix J, de Cuyper C, Ortonne JP. SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge. Contact Dermatitis. 2000 Jun;42(6):349-50.

 

Etudes de Phase 1

 Clinical trials in dermatology. The phase I trials.
J.Czernielewski, C. Queille-Roussel et al. 

 Thérapie (1991) 46: 183-187

 

 Clinical trials in dermatology. Evaluation of the tolerability and efficacy inflammatory treatment in atopic dermatitis.
C. Queille-Roussel, C. Dahan et al.

Thérapie (1991) 46:193-196

 

Clinical trials in dermatology. Evaluation of the tolerability and efficacy antipsoriatic treatment.  C. Dahan, C. Queille-Roussel et al.

Thérapie (1991) 46:197-200

 

Clinical trials in dermatology. Evaluation of the tolerability and efficacy agent in the treatment of superficial mycoses.
C. Queille-Roussel, C. Dahan et al.

Thérapie (1991) 46:201-204

 

Clinical trials in dermatology. Statistical support.
L. Duteil, C. Dahan et al.

Thérapie. 1991 May-Jun;46(3):205-9